Term Name: ritlecitinib tosylate
Synonyms: 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one 4-methylbenzenesulfonate (1:1), 1-{(2S,5R)-2-methyl-5-[(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}prop-2-en-1-one 4 methylbenzene-1-sulfonic acid, 4-methylbenzene-1-sulfonic acid--1-{(2S,5R)-2-methyl-5-[(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}prop-2-en-1-one (1/1), Litfulo, PF-06651600 tosylate, ritlecitinib tosilate
Definition: An organosulfonate salt obtained by combining equimolar amounts of ritlecitinib and 4-toluenesulfonic acid. It is a kinase inhibitor, developed by Pfizer for the treatment of severe alopecia areata in adults and adolescents 12 years and older.
Ontology: ChEBI [CHEBI:229234]  ( EBI )

Relationships
is a type of: organosulfonate salt
has_part: ritlecitinib(1+)
has_role: anti-inflammatory drug antirheumatic drug dermatologic drug EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor immunosuppressive agent